RIGLRigel PharmaceuticalsRIGL info
$13.82info1.36%24h
Global rank4619
Market cap$2.41B
Change 7d5.70%
YTD Performance852.76%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Rigel Pharmaceuticals (RIGL) Stock Overview

    Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company's commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; and Rezlidhia, a non-intensive monotherapy for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. It also develops Fostamatinib that has conducted phase III clinical trials for the treatment of warm autoimmune hemolytic anemia; has completed FOCUS phase III clinical trial for the treatment of hospitalized high-risk patients COVID-19; and that is in phase II/III clinical trials for the treatment of COVID-19 in hospitalized patients. In addition, the company's other clinical programs include interleukin receptor-associated kinase inhibitor program and a receptor-interacting serine/threonine-protein kinase inhibitor program in clinical development with partner Eli Lilly and Company. Further, it has product candidates in clinical development with partners BerGenBio ASA and Daiichi Sankyo. The company has strategic development collaboration with The University of Texas MD Anderson Cancer Center for the development of REZLIDHIA (Olutasidenib) in acute myeloid leukemia (AML) and other hematologic cancers. The company was incorporated in 1996 and is headquartered in South San Francisco, California.

    RIGL Stock Information

    Symbol
    RIGL
    Address
    611 Gateway BlvdSouth San Francisco, CA 94080United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.rigel.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    650 624 1100

    Rigel Pharmaceuticals (RIGL) Price Chart

    -
    Value:-

    Rigel Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $13.81
    N/A
    Market Cap
    $2.41B
    N/A
    Shares Outstanding
    174.37M
    N/A
    Employees
    155.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org